Home » Rigel Hit By Asthma Drug Failure
Rigel Hit By Asthma Drug Failure
August 27, 2013
Rigel’s SKY inhibitor R343, intended to treat asthma, failed to meet both of its endpoints in a mid-stage clinical trial. The company’s stock dropped nearly 20 percent upon announcement of the unfavorable results.
Pharma Times
Pharma Times
Upcoming Events
-
21Oct